Incannex Healthcare Limited (IXHL)
IXHL Stock Price Chart
Explore Incannex Healthcare Limited interactive price chart. Choose custom timeframes to analyze IXHL price movements and trends.
IXHL Company Profile
Discover essential business fundamentals and corporate details for Incannex Healthcare Limited (IXHL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2 Mar 2022
Employees
9.00
Website
https://www.incannex.com.auCEO
Joel Bradley Latham
Description
Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid compounds under its proprietary Incannex brand. Its product pipeline includes several key assets: IHL-42X: This compound is currently undergoing Phase II clinical evaluation for the treatment of obstructive sleep apnea (OSA). Incannex partners with The Alfred Hospital and Novotech on this specific clinical program. IHL-216A: Designed to address traumatic brain injury (TBI). Furthermore, the Monash Trauma Group, part of Monash University's Department of Neuroscience, is conducting a study on IHL-216A's protective effects against sports-related concussions. IHL-675A: A unique formulation combining hydroxychloroquine and cannabidiol, developed for both the prevention and management of a range of inflammatory conditions. These include acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, bronchitis, rheumatoid arthritis, and inflammatory bowel diseases. Originally established in 2001 as Impression Healthcare Limited, the company officially changed its name to Incannex Healthcare Limited in June 2020. Incannex maintains its corporate headquarters in Sydney, Australia.
IXHL Financial Timeline
Browse a chronological timeline of Incannex Healthcare Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Oct 2026
EPS estimate is $0.13.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.14, while revenue estimate is $200.00k.
Earnings released on 15 May 2026
EPS came in at -$0.34 surpassing the estimated -$0.60 by +44.17%.
Earnings released on 15 May 2026
EPS came in at -$0.60 matching the estimated -$0.60.
Stock split effective on 27 Feb 2026
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Sept 2025
EPS came in at -$0.39 falling short of the estimated -$0.29 by -34.48%, while revenue for the quarter reached $66.62k , missing expectations by -66.69%.
Earnings released on 15 May 2025
EPS came in at -$1.01 .
Earnings released on 15 May 2025
EPS came in at -$0.24 surpassing the estimated -$0.46 by +47.83%, while revenue for the quarter reached $19.38k , missing expectations by -93.79%.
Earnings released on 14 Nov 2024
EPS came in at -$1.36 , while revenue for the quarter reached $108.99k .
Earnings released on 30 Sept 2024
EPS came in at -$0.39 surpassing the estimated -$0.76 by +48.68%, while revenue for the quarter reached $17.97k , missing expectations by -88.41%.
Earnings released on 15 May 2024
EPS came in at -$1.76 .
Earnings released on 1 Mar 2024
EPS came in at -$1.45 .
Earnings released on 1 Dec 2023
EPS came in at $9.08 .
Stock split effective on 30 Nov 2023
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Sept 2023
EPS came in at -$0.21 .
Earnings released on 30 Mar 2023
EPS came in at -$1.00 .
Earnings released on 31 Dec 2022
EPS came in at -$0.83 .
Earnings released on 30 Sept 2022
EPS came in at -$4.13 .
Earnings released on 2 Sept 2022
EPS came in at -$0.32 , while revenue for the quarter reached $270.09k .
Earnings released on 31 Mar 2022
EPS came in at -$0.35 , while revenue for the quarter reached $292.74k .
Earnings released on 31 Dec 2021
EPS came in at -$0.20 .
Earnings released on 30 Sept 2021
EPS came in at -$0.20 .
IXHL Stock Performance
Access detailed IXHL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
